Comprehensive Evaluation of Antimicrobial Usage in The Intensive Care Unit

Abstract

Background
Infections are a common and significant challenge in Intensive Care Units (ICUs), leading to 
widespread use of antimicrobial agents (AMAs) for both prophylaxis and treatment. 
Critically ill patients are especially susceptible to infections due to factors like invasive 
procedures, immune compromise, and cross-contamination, making effective antimicrobial 
management essential. However, the frequent use of AMAs also increases the risk of 
polypharmacy and antimicrobial resistance.